サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1193067

頭蓋内動脈瘤市場：タイプ別（外科的クリッピング、血管内コイル、フローダイバータ、その他）、エンドユーザー別（病院、診療所、その他）：世界の機会分析および 産業予測、2021-2031年

Intracranial Aneurysm Market By Type (Surgical Clipping, Endovascular Coiling, Flow Diverters, Others), By End User (Hospitals, Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日: | 発行: Allied Market Research | ページ情報: 英文 243 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
頭蓋内動脈瘤市場：タイプ別（外科的クリッピング、血管内コイル、フローダイバータ、その他）、エンドユーザー別（病院、診療所、その他）：世界の機会分析および 産業予測、2021-2031年
出版日: 2022年10月01日
発行: Allied Market Research
ページ情報: 英文 243 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の頭蓋内動脈瘤市場は、2021年に13億189万米ドルと評価され、2031年には27億979万米ドルに達し、2022年から2031年までのCAGRは7.6％と予測されています。

脳動脈または頭蓋内動脈瘤は、血管壁の内側の筋肉層（内膜）の弱化により生じる脳の動脈の異常局所拡張であり、この拡張は、脳動脈瘤の原因となります。血管は「水ぶくれ」のような拡張を起こし、薄くなり、前触れもなく破裂することがあります。その結果、脳の周りの空間に出血し、これをクモ膜下出血（SAH）と呼びます。このような出血は、脳卒中、昏睡、死亡につながる可能性があります。

動脈瘤は通常、脳の底部、頭蓋骨のすぐ内側、クモ膜下腔と呼ばれる領域に存在します。実際、くも膜下出血（SAH）の90％は脳動脈瘤の破裂が原因となっています。しかし、脳動脈瘤の形成には、高血圧、喫煙、先天性素因、血管の損傷・外傷、ある種の血液感染症による合併症など、様々な要因があると考えられています。

市場の成長を牽引する主な要因としては、脳血管障害の患者数の増加や高血圧を患う老年人口の急増などが挙げられます。例えば、脳動脈瘤財団が発表した報告書によると、米国では未破裂の脳動脈瘤を持つ人が650万人、すなわち50人に1人いると推定されています。また、年間の破裂率は10万人あたり約8～10人であり、米国では毎年約3万人が脳動脈瘤の破裂に悩まされています。さらに、男性よりも女性の方が脳動脈瘤になりやすく（3：2の割合）、特に55歳以上の方は男性よりも脳動脈瘤破裂のリスクが高い（約1.5倍のリスク）ことが報告されています。脳動脈瘤による死亡者は世界で年間50万人近くおり、その半数は50歳以下の若年層です。脳血管疾患は、高血圧や喫煙、不健康な生活習慣などにより、血管が傷つき、脳動脈瘤ができることが原因とされています。さらに、低侵襲手術の需要の増加は、小さな切開は、術後の痛みを減少させ、開頭手術のためのこれらの手順の高い採用につながる迅速な回復を容易にするように、市場の成長を後押しします。多くの主要企業が、革新的な低侵襲血管内コイリング器具の発売のための研究開発活動に継続的に投資しており、市場の成長を促進すると予想されます。

しかし、動脈瘤によるくも膜下出血の管理コストの高さや手術中の健康リスクの高さが市場成長を阻害しています。一方、基本的な医療を受けられない発展途上国や低所得国の新興ヘルスケア市場、パンデミックや高血圧関連疾患のリスクの増加は、予測期間中に市場成長のための有利な機会を提供すると予想されます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資ポケット
  • ポーターのファイブフォース分析
  • 主要企業のポジショニング
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • COVID-19 影響分析

第4章 頭蓋内動脈瘤市場：タイプ別

  • 概要
    • 市場規模および予測
  • 外科手術用クリッピング
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • 血管内コイリング
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • フローダイバーター
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • その他
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別

第5章 頭蓋内動脈瘤市場：エンドユーザー別

  • 概要
    • 市場規模・予測
  • 病院
    • 主な市場動向、成長要因と機会
    • 市場規模・予測： 地域別
    • 市場分析：国別
  • 診療所
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • その他
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別

第6章 頭蓋内動脈瘤市場：地域別

  • 概要
    • 市場規模・予測
  • 北米
    • 主な動向と機会
    • 北米市場規模・予測：タイプ別
    • 北米市場規模・予測：エンドユーザー別
    • 北米市場規模・予測：国別
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • 主な動向と機会
    • 欧州市場規模・予測：タイプ別
    • 欧州市場規模・予測：エンドユーザー別
    • 欧州市場規模・予測：国別
      • ドイツ
      • フランス
      • 英国
      • イタリア
      • スペイン
      • その他欧州
  • アジア太平洋地域
    • 主な動向と機会
    • アジア太平洋地域の市場規模・予測：タイプ別
    • アジア太平洋地域の市場規模・予測：エンドユーザー別
    • アジア太平洋地域の市場規模・予測：国別
      • 日本
      • 中国
      • オーストラリア
      • インド
      • 韓国
      • その他アジア太平洋地域
  • LAMEA
    • 主な動向と機会
    • LAMEAの市場規模・予測：タイプ別
    • LAMEAの市場規模・予測：エンドユーザー別
    • LAMEAの市場規模・予測：国別
      • ブラジル
      • サウジアラビア
      • 南アフリカ共和国
      • LAMEAの残りの地域

第7章 企業情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主な発展

第8章 企業プロファイル

  • B. Braun
  • Delta Surgical
  • Evonos GmbH & Co. KG
  • Integra Life-science Holding Corporation
  • Medtronic PLC
  • Microport Scientific Corporation
  • Mizuho Medical Incorporation
  • Spiegelberg
  • Stryker Corporation
  • Terumo Global（Microvention）
図表

LIST OF TABLES

  • TABLE 1. GLOBAL INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 2. INTRACRANIAL ANEURYSM MARKET, FOR SURGICAL CLIPPING, BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. INTRACRANIAL ANEURYSM MARKET FOR SURGICAL CLIPPING, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. INTRACRANIAL ANEURYSM MARKET, FOR ENDOVASCULAR COILING, BY REGION, 2021-2031 ($MILLION)
  • TABLE 5. INTRACRANIAL ANEURYSM MARKET FOR ENDOVASCULAR COILING, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 6. INTRACRANIAL ANEURYSM MARKET, FOR FLOW DIVERTERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 7. INTRACRANIAL ANEURYSM MARKET FOR FLOW DIVERTERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 8. INTRACRANIAL ANEURYSM MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 9. INTRACRANIAL ANEURYSM MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 10. GLOBAL INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 11. INTRACRANIAL ANEURYSM MARKET, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 12. INTRACRANIAL ANEURYSM MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 13. INTRACRANIAL ANEURYSM MARKET, FOR CLINICS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 14. INTRACRANIAL ANEURYSM MARKET FOR CLINICS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 15. INTRACRANIAL ANEURYSM MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 16. INTRACRANIAL ANEURYSM MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 17. INTRACRANIAL ANEURYSM MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 18. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 19. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 20. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 21. U.S. INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 22. U.S. INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 23. CANADA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 24. CANADA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 25. MEXICO INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 26. MEXICO INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 27. EUROPE INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 28. EUROPE INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 29. EUROPE INTRACRANIAL ANEURYSM MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 30. GERMANY INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 31. GERMANY INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 32. FRANCE INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 33. FRANCE INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 34. UK INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 35. UK INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 36. ITALY INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 37. ITALY INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 38. SPAIN INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 39. SPAIN INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 40. REST OF EUROPE INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 41. REST OF EUROPE INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 42. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 43. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 44. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 45. JAPAN INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 46. JAPAN INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 47. CHINA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 48. CHINA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 49. AUSTRALIA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 50. AUSTRALIA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 51. INDIA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 52. INDIA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 53. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 54. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 55. REST OF ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 56. REST OF ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 57. LAMEA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 58. LAMEA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 59. LAMEA INTRACRANIAL ANEURYSM MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 60. BRAZIL INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 61. BRAZIL INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 62. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 63. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 64. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 65. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 66. REST OF LAMEA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 67. REST OF LAMEA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 68.B. BRAUN: COMPANY SNAPSHOT
  • TABLE 69.B. BRAUN: OPERATING SEGMENTS
  • TABLE 70.B. BRAUN: PRODUCT PORTFOLIO
  • TABLE 71.B. BRAUN: NET SALES,
  • TABLE 72.B. BRAUN: KEY STRATERGIES
  • TABLE 73.DELTA SURGICAL: COMPANY SNAPSHOT
  • TABLE 74.DELTA SURGICAL: OPERATING SEGMENTS
  • TABLE 75.DELTA SURGICAL: PRODUCT PORTFOLIO
  • TABLE 76.DELTA SURGICAL: NET SALES,
  • TABLE 77.DELTA SURGICAL: KEY STRATERGIES
  • TABLE 78.EVONOS GMBH & CO. KG: COMPANY SNAPSHOT
  • TABLE 79.EVONOS GMBH & CO. KG: OPERATING SEGMENTS
  • TABLE 80.EVONOS GMBH & CO. KG: PRODUCT PORTFOLIO
  • TABLE 81.EVONOS GMBH & CO. KG: NET SALES,
  • TABLE 82.EVONOS GMBH & CO. KG: KEY STRATERGIES
  • TABLE 83.INTEGRA LIFE-SCIENCE HOLDING CORPORATION: COMPANY SNAPSHOT
  • TABLE 84.INTEGRA LIFE-SCIENCE HOLDING CORPORATION: OPERATING SEGMENTS
  • TABLE 85.INTEGRA LIFE-SCIENCE HOLDING CORPORATION: PRODUCT PORTFOLIO
  • TABLE 86.INTEGRA LIFE-SCIENCE HOLDING CORPORATION: NET SALES,
  • TABLE 87.INTEGRA LIFE-SCIENCE HOLDING CORPORATION: KEY STRATERGIES
  • TABLE 88.MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 89.MEDTRONIC PLC: OPERATING SEGMENTS
  • TABLE 90.MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 91.MEDTRONIC PLC: NET SALES,
  • TABLE 92.MEDTRONIC PLC: KEY STRATERGIES
  • TABLE 93.MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 94.MICROPORT SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 95.MICROPORT SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 96.MICROPORT SCIENTIFIC CORPORATION: NET SALES,
  • TABLE 97.MICROPORT SCIENTIFIC CORPORATION: KEY STRATERGIES
  • TABLE 98.MIZUHO MEDICAL INCORPORATION: COMPANY SNAPSHOT
  • TABLE 99.MIZUHO MEDICAL INCORPORATION: OPERATING SEGMENTS
  • TABLE 100.MIZUHO MEDICAL INCORPORATION: PRODUCT PORTFOLIO
  • TABLE 101.MIZUHO MEDICAL INCORPORATION: NET SALES,
  • TABLE 102.MIZUHO MEDICAL INCORPORATION: KEY STRATERGIES
  • TABLE 103.SPIEGELBERG: COMPANY SNAPSHOT
  • TABLE 104.SPIEGELBERG: OPERATING SEGMENTS
  • TABLE 105.SPIEGELBERG: PRODUCT PORTFOLIO
  • TABLE 106.SPIEGELBERG: NET SALES,
  • TABLE 107.SPIEGELBERG: KEY STRATERGIES
  • TABLE 108.STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 109.STRYKER CORPORATION: OPERATING SEGMENTS
  • TABLE 110.STRYKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 111.STRYKER CORPORATION: NET SALES,
  • TABLE 112.STRYKER CORPORATION: KEY STRATERGIES
  • TABLE 113.TERUMO GLOBAL (MICROVENTION): COMPANY SNAPSHOT
  • TABLE 114.TERUMO GLOBAL (MICROVENTION): OPERATING SEGMENTS
  • TABLE 115.TERUMO GLOBAL (MICROVENTION): PRODUCT PORTFOLIO
  • TABLE 116.TERUMO GLOBAL (MICROVENTION): NET SALES,
  • TABLE 117.TERUMO GLOBAL (MICROVENTION): KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.INTRACRANIAL ANEURYSM MARKET SEGMENTATION
  • FIGURE 2.INTRACRANIAL ANEURYSM MARKET,2021-2031
  • FIGURE 3.INTRACRANIAL ANEURYSM MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.INTRACRANIAL ANEURYSM MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.INTRACRANIAL ANEURYSM MARKET,BY TYPE,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF SURGICAL CLIPPING INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF ENDOVASCULAR COILING INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF FLOW DIVERTERS INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF OTHERS INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
  • FIGURE 17.INTRACRANIAL ANEURYSM MARKET,BY END USER,2021(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF HOSPITALS INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF CLINICS INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF OTHERS INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
  • FIGURE 21.INTRACRANIAL ANEURYSM MARKET BY REGION,2021
  • FIGURE 22.U.S. INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 23.CANADA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 24.MEXICO INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 25.GERMANY INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 26.FRANCE INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 27.UK INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 28.ITALY INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 29.SPAIN INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 30.REST OF EUROPE INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 31.JAPAN INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 32.CHINA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 33.AUSTRALIA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 34.INDIA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 35.SOUTH KOREA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 36.REST OF ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 37.BRAZIL INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 38.SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 39.SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 40.REST OF LAMEA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 41. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 44.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 45.COMPETITIVE DASHBOARD
  • FIGURE 46.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 47.B. BRAUN.: NET SALES ,($MILLION)
  • FIGURE 48.DELTA SURGICAL.: NET SALES ,($MILLION)
  • FIGURE 49.EVONOS GMBH & CO. KG.: NET SALES ,($MILLION)
  • FIGURE 50.INTEGRA LIFE-SCIENCE HOLDING CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 51.MEDTRONIC PLC.: NET SALES ,($MILLION)
  • FIGURE 52.MICROPORT SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 53.MIZUHO MEDICAL INCORPORATION.: NET SALES ,($MILLION)
  • FIGURE 54.SPIEGELBERG.: NET SALES ,($MILLION)
  • FIGURE 55.STRYKER CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 56.TERUMO GLOBAL (MICROVENTION).: NET SALES ,($MILLION)
目次
Product Code: A10205

The global intracranial aneurysm market was valued at $1,301.89 million in 2021, and is projected to reach $2,709.79 million by 2031, registering a CAGR of 7.6% from 2022 to 2031.A cerebral or intracranial aneurysm is an abnormal focal dilation of an artery in the brain that results from weakening of the inner muscular layer (the intima) of a blood vessel wall. The vessel develops a "blister-like" dilation that can become thin and rupture without warning. This results in bleeding into the space around the brain, which is called a subarachnoid hemorrhage (SAH). This kind of hemorrhage can lead to a stroke, coma, and/or death.

Aneurysms are usually found at the base of brain, just inside the skull, in an area called subarachnoid space. In fact, ruptured cerebral aneurysms are responsible for 90% of subarachnoid hemorrhage (SAH). However, a number of factors are believed to contribute in formation of cerebral aneurysms, including hypertension, smoking, congenital predisposition, injury, or trauma to blood vessels and complications from some types of blood infections.

Key factors that drive growth of the market include rise in number of patients suffering from cerebrovascular disease and surge in geriatric population suffering from hypertension. For instance, according to a report published by the Brain Aneurysm Foundation, it has been estimated that 6.5 million people in the U.S. have an unruptured brain aneurysm i.e., 1 in 50 people. The annual rate of rupture is approximately 8-10 per 100,000 people and around 30,000 people in the U.S. suffer a brain aneurysm rupture each year. Moreover, it has been reported that women are more likely than men to have a brain aneurysm (3:2 ratio), particularly those over the age of 55 have a higher risk of brain aneurysm rupture than men (about 1.5 times the risk). There are almost 500,000 deaths worldwide each year caused by brain aneurysms, and half the victims are younger than 50. The reason behind rise in prevalence of cerebrovascular disease are hypertension, cigarette smoking, and unhealthy lifestyle which leads to injury or trauma to blood vessels causing brain aneurysm. Furthermore, rise in the demand for minimally invasive surgeries, as smaller incisions decrease postoperative pain and facilitate speedy recovery leading to high adoption of these procedures for craniotomy surgery boost the market growth. Numerous key players are continuously investing in R&D activities for the launch of innovative minimally invasive endovascular coiling instruments are anticipated to fuel the market growth.

However, high management cost of aneurysm subarachnoid hemorrhage and high health risk during surgeries hamper the market growth. Conversely, emerging healthcare markets in developing countries and low-income countries lacking access to basic healthcare and increase in risk of pandemic and hypertension related disorders is expected to provide the lucrative opportunity for the growth of market during the forecast period. 

The intracranial aneurysm market is segmented on the basis of type, end user, and region. By type the market is segmented into surgical clipping, endovascular coiling, flow diverters, and others. By end user, it segmented into hospitals, clinics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

North America accounted for a majority of the intracranial aneurysm market share in 2021, and is anticipated to remain dominant during the forecast period, owing to the presence of well-established healthcare facilities, a growing geriatric population, and a high incidence of hypertension and stroke. Moreover, increase in prevalence of intracranial aneurysms and rise in demand for minimally invasive procedures contribute toward the market growth in the region. Furthermore, increase in number of initiatives undertaken by various organizations to spread awareness and reduce number of deaths due to cerebral aneurysms through innovative research is expected to fuel the market growth.

Asia-Pacific is expected to register fastest CAGR during the forecast period. This is attributed to presence of high unmet medical needs and constantly improving healthcare infrastructure. In addition, rapidly growing geriatric population, lifestyle stress, rise in incidences of hypertension, large population, improvement in quality of diagnosis, and increase in patient affordability are expected to drive the market in Asia-Pacific. This helps several market players to invest in Asia-Pacific countries, which further contributes toward growth of the market.

Key players that operate in the Intracranial aneurysm market are B. Braun, Delta Surgical, Evonos GmbH & Co. KG, Integra Lifescience Holding Corporation, Medtronic PLC, Microport Scientific Corporation, Mizuho Medical Incorporation, Spiegelberg, Stryker Corporation, and Terumo Global (Microvention).

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the intracranial aneurysm market analysis from 2021 to 2031 to identify the prevailing intracranial aneurysm market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the intracranial aneurysm market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global intracranial aneurysm market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Surgical Clipping
  • Endovascular Coiling
  • Flow Diverters
  • Others

By End User

  • Hospitals
  • Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Rest of Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • B. Braun
    • Delta Surgical
    • Evonos GmbH & Co. KG
    • Integra Life-science Holding Corporation
    • Medtronic PLC
    • Microport Scientific Corporation
    • Mizuho Medical Incorporation
    • Spiegelberg
    • Stryker Corporation
    • Terumo Global (Microvention)

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: INTRACRANIAL ANEURYSM MARKET, BY TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Surgical Clipping
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Endovascular Coiling
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Flow Diverters
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country
  • 4.5 Others
    • 4.5.1 Key market trends, growth factors and opportunities
    • 4.5.2 Market size and forecast, by region
    • 4.5.3 Market analysis by country

CHAPTER 5: INTRACRANIAL ANEURYSM MARKET, BY END USER

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Hospitals
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Clinics
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Others
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country

CHAPTER 6: INTRACRANIAL ANEURYSM MARKET, BY REGION

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 North America
    • 6.2.1 Key trends and opportunities
    • 6.2.2 North America Market size and forecast, by Type
    • 6.2.3 North America Market size and forecast, by End User
    • 6.2.4 North America Market size and forecast, by country
      • 6.2.4.1 U.S.
      • 6.2.4.1.1 Market size and forecast, by Type
      • 6.2.4.1.2 Market size and forecast, by End User
      • 6.2.4.2 Canada
      • 6.2.4.2.1 Market size and forecast, by Type
      • 6.2.4.2.2 Market size and forecast, by End User
      • 6.2.4.3 Mexico
      • 6.2.4.3.1 Market size and forecast, by Type
      • 6.2.4.3.2 Market size and forecast, by End User
  • 6.3 Europe
    • 6.3.1 Key trends and opportunities
    • 6.3.2 Europe Market size and forecast, by Type
    • 6.3.3 Europe Market size and forecast, by End User
    • 6.3.4 Europe Market size and forecast, by country
      • 6.3.4.1 Germany
      • 6.3.4.1.1 Market size and forecast, by Type
      • 6.3.4.1.2 Market size and forecast, by End User
      • 6.3.4.2 France
      • 6.3.4.2.1 Market size and forecast, by Type
      • 6.3.4.2.2 Market size and forecast, by End User
      • 6.3.4.3 UK
      • 6.3.4.3.1 Market size and forecast, by Type
      • 6.3.4.3.2 Market size and forecast, by End User
      • 6.3.4.4 Italy
      • 6.3.4.4.1 Market size and forecast, by Type
      • 6.3.4.4.2 Market size and forecast, by End User
      • 6.3.4.5 Spain
      • 6.3.4.5.1 Market size and forecast, by Type
      • 6.3.4.5.2 Market size and forecast, by End User
      • 6.3.4.6 Rest of Europe
      • 6.3.4.6.1 Market size and forecast, by Type
      • 6.3.4.6.2 Market size and forecast, by End User
  • 6.4 Asia-Pacific
    • 6.4.1 Key trends and opportunities
    • 6.4.2 Asia-Pacific Market size and forecast, by Type
    • 6.4.3 Asia-Pacific Market size and forecast, by End User
    • 6.4.4 Asia-Pacific Market size and forecast, by country
      • 6.4.4.1 Japan
      • 6.4.4.1.1 Market size and forecast, by Type
      • 6.4.4.1.2 Market size and forecast, by End User
      • 6.4.4.2 China
      • 6.4.4.2.1 Market size and forecast, by Type
      • 6.4.4.2.2 Market size and forecast, by End User
      • 6.4.4.3 Australia
      • 6.4.4.3.1 Market size and forecast, by Type
      • 6.4.4.3.2 Market size and forecast, by End User
      • 6.4.4.4 India
      • 6.4.4.4.1 Market size and forecast, by Type
      • 6.4.4.4.2 Market size and forecast, by End User
      • 6.4.4.5 South Korea
      • 6.4.4.5.1 Market size and forecast, by Type
      • 6.4.4.5.2 Market size and forecast, by End User
      • 6.4.4.6 Rest of Asia-Pacific
      • 6.4.4.6.1 Market size and forecast, by Type
      • 6.4.4.6.2 Market size and forecast, by End User
  • 6.5 LAMEA
    • 6.5.1 Key trends and opportunities
    • 6.5.2 LAMEA Market size and forecast, by Type
    • 6.5.3 LAMEA Market size and forecast, by End User
    • 6.5.4 LAMEA Market size and forecast, by country
      • 6.5.4.1 Brazil
      • 6.5.4.1.1 Market size and forecast, by Type
      • 6.5.4.1.2 Market size and forecast, by End User
      • 6.5.4.2 Saudi Arabia
      • 6.5.4.2.1 Market size and forecast, by Type
      • 6.5.4.2.2 Market size and forecast, by End User
      • 6.5.4.3 South Africa
      • 6.5.4.3.1 Market size and forecast, by Type
      • 6.5.4.3.2 Market size and forecast, by End User
      • 6.5.4.4 Rest of LAMEA
      • 6.5.4.4.1 Market size and forecast, by Type
      • 6.5.4.4.2 Market size and forecast, by End User

CHAPTER 7: COMPANY LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Key developments

CHAPTER 8: COMPANY PROFILES

  • 8.1 B. Braun
    • 8.1.1 Company overview
    • 8.1.2 Company snapshot
    • 8.1.3 Operating business segments
    • 8.1.4 Product portfolio
    • 8.1.5 Business performance
    • 8.1.6 Key strategic moves and developments
  • 8.2 Delta Surgical
    • 8.2.1 Company overview
    • 8.2.2 Company snapshot
    • 8.2.3 Operating business segments
    • 8.2.4 Product portfolio
    • 8.2.5 Business performance
    • 8.2.6 Key strategic moves and developments
  • 8.3 Evonos GmbH & Co. KG
    • 8.3.1 Company overview
    • 8.3.2 Company snapshot
    • 8.3.3 Operating business segments
    • 8.3.4 Product portfolio
    • 8.3.5 Business performance
    • 8.3.6 Key strategic moves and developments
  • 8.4 Integra Life-science Holding Corporation
    • 8.4.1 Company overview
    • 8.4.2 Company snapshot
    • 8.4.3 Operating business segments
    • 8.4.4 Product portfolio
    • 8.4.5 Business performance
    • 8.4.6 Key strategic moves and developments
  • 8.5 Medtronic PLC
    • 8.5.1 Company overview
    • 8.5.2 Company snapshot
    • 8.5.3 Operating business segments
    • 8.5.4 Product portfolio
    • 8.5.5 Business performance
    • 8.5.6 Key strategic moves and developments
  • 8.6 Microport Scientific Corporation
    • 8.6.1 Company overview
    • 8.6.2 Company snapshot
    • 8.6.3 Operating business segments
    • 8.6.4 Product portfolio
    • 8.6.5 Business performance
    • 8.6.6 Key strategic moves and developments
  • 8.7 Mizuho Medical Incorporation
    • 8.7.1 Company overview
    • 8.7.2 Company snapshot
    • 8.7.3 Operating business segments
    • 8.7.4 Product portfolio
    • 8.7.5 Business performance
    • 8.7.6 Key strategic moves and developments
  • 8.8 Spiegelberg
    • 8.8.1 Company overview
    • 8.8.2 Company snapshot
    • 8.8.3 Operating business segments
    • 8.8.4 Product portfolio
    • 8.8.5 Business performance
    • 8.8.6 Key strategic moves and developments
  • 8.9 Stryker Corporation
    • 8.9.1 Company overview
    • 8.9.2 Company snapshot
    • 8.9.3 Operating business segments
    • 8.9.4 Product portfolio
    • 8.9.5 Business performance
    • 8.9.6 Key strategic moves and developments
  • 8.10 Terumo Global (Microvention)
    • 8.10.1 Company overview
    • 8.10.2 Company snapshot
    • 8.10.3 Operating business segments
    • 8.10.4 Product portfolio
    • 8.10.5 Business performance
    • 8.10.6 Key strategic moves and developments